Once-weekly prophylaxis with glycoPEGylated recombinant factor VIII (N8-GP) in severe haemophilia A: Safety and efficacy results from pathfinder 2 (randomized phase III trial). by Curry, N, Albayrak, C, Escobar, M, Andre Holme, P, Kearney, S, Klamroth, R, Misgav, M, Négrier, C, Wheeler, A, Santagostino, E, Shima, M, Landorph, A, Tønder, SM, Lentz, SR